Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trial

• Main Authors: Ke-Da Yu (Author), Xi-Yu Liu (Author), Li Chen (Author), Miao Mo (Author), Jiong Wu (Author), Guang-Yu Liu (Author), Gen-Hong Di (Author), Claire Verschraegen (Author), Daniel G. Stover (Author), Zhi-Gang Zhuang (Author), François Bertucci (Author), Armando Orlandi (Author), Jie Wang (Author), Giuseppe Lippi (Author), Ke-Jin Wu (Author), Mohammed A. Osman (Author), Lei Fan (Author), Zhi-Ming Shao (Author)
• Format: Book
• Published: Elsevier, 2021-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: De-escalating anthracycline is gaining popularity for breast cancer patients. We aim to evaluate the non-inferiority of an anthracycline-free or short-term regimen to the standard anthracycline-based regimen for operable patients with human epidermal growth factor receptor 2 (HER2)-negat...